From journals and scientific sources

313 topics in this forum

1. Important topics in Journals and Scientific Sources

   By Altostrata, May 12, 2011
   • 3 replies
   • 2,864 views
   • 
   • Altostrata
   • January 5

2. Primary sources for data, records, papers

   By Altostrata, May 1, 2011
   • 10 replies
   • 2,793 views
   • 
   • emilie
   • November 6, 2018

3. Papers about prolonged antidepressant withdrawal syndrome

   By Altostrata, May 22, 2011
   • 30 replies
   • 9,775 views
   • 
   • WiggleIt
   • November 6, 2018

4. Liver Enzymes Cytochrome P450 Drug Interaction Tables

   By Altostrata, November 17, 2011
   • 6 replies
   • 7,109 views
   • 
   • Altostrata
   • July 23, 2018

5. Official guides to tapering off psychiatric medications

   By Altostrata, December 24, 2012
   • 0 replies
   • 3,209 views
   • 
   • Altostrata
   • December 24, 2012

6. Before you start a topic in Journals....

   By Altostrata, June 29, 2012
   • 0 replies
   • 1,682 views
   • 
   • Altostrata
   • June 29, 2012

7. Khan, 2019 Serotonin Sensitivity and Withdrawal With Low-Dose Venlafaxine

   By Altostrata, April 9
   • 0 replies
   • 164 views
   • 
   • Altostrata
   • April 9

8. Moncrieff, 2005 Rethinking models of psychotropic drug action.

   By Altostrata, April 6
   • 0 replies
   • 76 views
   • 
   • Altostrata
   • April 6

9. Aydemir, 2018 SSRI Induced Apathy Syndrome

   By Altostrata, March 1
   • 1 reply
   • 123 views
   • 
   • ShiningLight
   • April 6

10. Récalt, 2019 Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000-2017.

    By Altostrata, March 27
    • 0 replies
    • 128 views
    • 
    • Altostrata
    • March 27

11. Horowitz, 2019 Tapering of SSRI treatment to mitigate withdrawal symptoms

    By Henosis, March 6
    • 7 replies
    • 506 views
    • 
    • Kittygiggles
    • March 26

12. Kanwaldeep, 2008 Watch for nonpsychotropics causing psychiatric side effects

    • 1
    • 2

    By btdt, April 23, 2014
    • 58 replies
    • 3,613 views
    • 
    • ghm2018
    • March 11

13. Veltri, 2015 Medication-induced hypokalemia

    By Altostrata, March 4
    • 0 replies
    • 35 views
    • 
    • Altostrata
    • March 4

14. Oehrberg, 1995 Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study.

    By Altostrata, January 27
    • 0 replies
    • 76 views
    • 
    • Altostrata
    • January 27

15. Andrews, 2012 Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good

    By Altostrata, April 25, 2012
    • 17 replies
    • 1,426 views
    • 
    • Altostrata
    • January 26

16. Maund, 2019 Managing Antidepressant Discontinuation: A Systematic Review.

    By Altostrata, January 26
    • 0 replies
    • 97 views
    • 
    • Altostrata
    • January 26

17. Papers about Post-SSRI Sexual Disorder (PSSD)

    • 1
    • 2

    By Altostrata, July 5, 2011   

    • pssd
    • sexual dysfunction
    • 36 replies
    • 16,830 views
    • 
    • Altostrata
    • January 19

18. Reisman, 2017 Sexual Consequences of Post-SSRI Syndrome.

    By Altostrata, January 19   

    • pssd
    • sexual dysfunction
    • 0 replies
    • 64 views
    • 
    • Altostrata
    • January 19

19. Bala, 2018 Post-SSRI Sexual Dysfunction: A Literature Review.

    By Altostrata, January 19   

    • pssd
    • sexual dysfunction
    • 0 replies
    • 76 views
    • 
    • Altostrata
    • January 19

20. Papp, 2018 Brain Zaps: An Underappreciated Symptom of Antidepressant Discontinuation.

    By Altostrata, January 5
    • 3 replies
    • 200 views
    • 
    • Linus
    • January 16

21. Harvey, 2014 New insights on antidepressant discontinuation syndrome

    By dalsaan, January 6, 2015
    • 2 replies
    • 902 views
    • 
    • Linus
    • January 16

22. Attfield, 2016 Preparation of Lower Dosages of SNRI Antidepressants to Ameliorate Discontinuation Symptoms: Two Case Studies

    By Andie, December 16, 2018   

    • snri
    • compounding
    • (and 5 more)

      Tagged with:

      • snri
      • compounding
      • pristiq
      • cymbalta
      • desvelafaxine
      • duloxetine
      • venlafaxine
    • 1 reply
    • 129 views
    • 
    • Altostrata
    • January 5

23. Khan, 2014 Abrupt discontinuation compared with a 1-week taper regimen in depressed outpatients treated for 24 weeks with desvenlafaxine 50 mg/d.

    By Altostrata, January 5
    • 0 replies
    • 73 views
    • 
    • Altostrata
    • January 5

24. Eveleigh, 2017 Withdrawal of unnecessary antidepressant medication: a randomised controlled trial in primary care

    By Shep, November 19, 2017
    • 14 replies
    • 928 views
    • 
    • Altostrata
    • January 5

25. Frankel, 2018 An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.

    By Andie, December 18, 2018   

    • sert
    • pristiq
    • (and 1 more)

      Tagged with:

      • sert
      • pristiq
      • desvenlafaxine
    • 2 replies
    • 155 views
    • 
    • Altostrata
    • January 5

26. Berwian, 2017 Predicting relapse after antidepressant withdrawal - a systematic review.

    By Altostrata, September 11, 2018
    • 5 replies
    • 273 views
    • 
    • Altostrata
    • January 1

27. Jha, 2018 When Discontinuing SSRI Antidepressants Is a Challenge: Management Tips.

    By Altostrata, December 31, 2018
    • 0 replies
    • 164 views
    • 
    • Altostrata
    • December 31, 2018

28. Fornaro, 2018 The Emergence of loss of efficacy during Antidepressant Drug Treatment for Major Depressive Disorder: An Integrative Review of Evidence, Mechanisms, and Clinical Implications.

    By Altostrata, November 3, 2018   

    • tachyphylaxis
    • poop-out
    • (and 2 more)

      Tagged with:

      • tachyphylaxis
      • poop-out
      • breakthrough symptoms
      • tolerance
    • 1 reply
    • 132 views
    • 
    • Linus
    • December 22, 2018

29. Kaufmann, 2009 Selective Serotonin Reuptake Inhibitor (SSRI) Drugs: More Risks Than Benefits?

    By Altostrata, December 7, 2018
    • 0 replies
    • 133 views
    • 
    • Altostrata
    • December 7, 2018

30. Davies, 2018 A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?

    By Altostrata, October 29, 2018
    • 2 replies
    • 312 views
    • 
    • Bunyapine
    • November 3, 2018

31. Fava, 2018 Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review.

    By Altostrata, July 21, 2018
    • 2 replies
    • 393 views
    • 
    • Bridgetini
    • October 15, 2018

32. Carvalho, 2016 Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature.

    By Altostrata, April 4, 2018
    • 1 reply
    • 363 views
    • 
    • Barbarannamated
    • October 11, 2018

33. Ostrow, 2017 Discontinuing psychiatric medications: a survey of long-term users

    By bubbles, May 24, 2018
    • 9 replies
    • 477 views
    • 
    • bubbles
    • October 9, 2018

34. Zabegalov, 2018 Understanding antidepressant discontinuation syndrome (ADS) through preclinical experimental models.

    By Altostrata, July 12, 2018
    • 1 reply
    • 275 views
    • 
    • btdt
    • September 15, 2018

35. Bhat, 2017 Recognition and management of antidepressant discontinuation syndrome.

    By Altostrata, September 8, 2018
    • 11 replies
    • 310 views
    • 
    • Kittygiggles
    • September 12, 2018

36. Fava, 2018 Discontinuing Antidepressant Drugs: Lesson from a Failed Trial and Extensive Clinical Experience

    By Lilu, September 11, 2018
    • 3 replies
    • 204 views
    • 
    • Henosis
    • September 12, 2018